<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2016-4-88-91</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-83</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОФТАЛЬМОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPHTHALMOLOGY</subject></subj-group></article-categories><title-group><article-title>Вопросы терапии дистрофических изменений переднего отдела глаза</article-title><trans-title-group xml:lang="en"><trans-title>Questions of treatment of degenerative changes in the anterior chamber of the eye</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яни</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yani</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селиверстова</surname><given-names>К. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Seliverstova</surname><given-names>K. E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский научно-исследовательский институт глазных болезней имени Гельмгольца</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz Moscow Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2016</year></pub-date><volume>0</volume><issue>4</issue><fpage>88</fpage><lpage>91</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Яни Е.В., Селиверстова К.Е., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Яни Е.В., Селиверстова К.Е.</copyright-holder><copyright-holder xml:lang="en">Yani E.V., Seliverstova K.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/83">https://www.med-sovet.pro/jour/article/view/83</self-uri><abstract><p>Дегенеративные заболевания роговицы являются актуальной проблемой современной офтальмологии. Основными направлениями в лечении дегенеративных изменений переднего отдела глаза являются противовоспалительная, кератопротективная и слезозаместительная терапия. Препарат Визомитин глазные капли в лечении первичных и вторичных дистрофий роговицы обладает высокой терапевтической эффективностью и безопасностью применения.</p></abstract><trans-abstract xml:lang="en"><p>Degenerative corneal diseases represent a relevant issue in the present-day ophthalmology. The key areas in the treatment of degenerative changes in the anterior chamber of the eye are anti-inflammatory, keratoprotective and tear substitute therapies. Visomitin eye drops have high therapeutic efficacy and safety of use in the treatment of primary and secondary corneal dystrophies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Визомитин</kwd><kwd>глазные капли</kwd><kwd>дистрофия роговицы</kwd><kwd>Visomitin</kwd><kwd>eye drops</kwd><kwd>corneal dystrophy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yeh S, Song XJ, Farley W et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci, 2003, 44: 124-129.</mixed-citation><mixed-citation xml:lang="en">Yeh S, Song XJ, Farley W et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci, 2003, 44: 124-129.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wakamatsu TH, Dorgu M, Tsubota K. Teafui relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol, 2008, 71: 72-79.</mixed-citation><mixed-citation xml:lang="en">Wakamatsu TH, Dorgu M, Tsubota K. Teafui relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol, 2008, 71: 72-79.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бржеский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение). СПб., 2003. 119.</mixed-citation><mixed-citation xml:lang="en">Бржеский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение). СПб., 2003. 119.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall LL, Roach JM. Treatment of Dry Eye Disease. Consult Pharm, 2016, 31(2): 96-106.</mixed-citation><mixed-citation xml:lang="en">Marshall LL, Roach JM. Treatment of Dry Eye Disease. Consult Pharm, 2016, 31(2): 96-106.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Майчук Ю.Ф., Яни Е.В., Вахова Е.С. Синдром сухого глаза как последствие перенесенных офтальмоинфекций. Актуальные вопросы офтальмологии. М., 2000. 35-36.</mixed-citation><mixed-citation xml:lang="en">Майчук Ю.Ф., Яни Е.В., Вахова Е.С. Синдром сухого глаза как последствие перенесенных офтальмоинфекций. Актуальные вопросы офтальмологии. М., 2000. 35-36.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Khosrow Jadidi, Yunes Panahi, Ali Ebrahimi et. al. Topical Cyclosporine A for Treatment of Dry Eye Due to Chronic Mustard Gas Injury. J Ophthalmic Vis Res, 2014, 9(4): 417-422.</mixed-citation><mixed-citation xml:lang="en">Khosrow Jadidi, Yunes Panahi, Ali Ebrahimi et. al. Topical Cyclosporine A for Treatment of Dry Eye Due to Chronic Mustard Gas Injury. J Ophthalmic Vis Res, 2014, 9(4): 417-422.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY Roginsky VA, Rokitskaya TI, Severin FF, Severina II, Simonyan RA, Skulachev MV, Sumbatyan NV, Sukhanova EI, Tashlitsky VN, Trendeleva TA, Vyssokikh MY, Zvyagilskaya RA. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta, 2010,1797,(6-7): 878-89.</mixed-citation><mixed-citation xml:lang="en">Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY Roginsky VA, Rokitskaya TI, Severin FF, Severina II, Simonyan RA, Skulachev MV, Sumbatyan NV, Sukhanova EI, Tashlitsky VN, Trendeleva TA, Vyssokikh MY, Zvyagilskaya RA. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta, 2010,1797,(6-7): 878-89.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brzheskiy V.V., Somov E.E. Corneal-conjunctival xerosis (diagnosis, clinical pattern, treatment). SPb., 2003. 119.</mixed-citation><mixed-citation xml:lang="en">Brzheskiy V.V., Somov E.E. Corneal-conjunctival xerosis (diagnosis, clinical pattern, treatment). SPb., 2003. 119.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Maychuk Y.F., Yani E.V., Vakhova E.S. Dry eye syndrome as a consequence of ophtalmic injections. Aktualnye Voprosy Oftalmologii. М., 2000. 35-36</mixed-citation><mixed-citation xml:lang="en">Maychuk Y.F., Yani E.V., Vakhova E.S. Dry eye syndrome as a consequence of ophtalmic injections. Aktualnye Voprosy Oftalmologii. М., 2000. 35-36</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
